Status:
RECRUITING
Evaluating DyNamic Myocardial Blood Flow QUantitation As a Cost Effective Care ModeL for DiabEtic Patients With Coronary Artery DiSease
Lead Sponsor:
National Heart Centre Singapore
Collaborating Sponsors:
National Medical Research Council (NMRC), Singapore
Conditions:
Coronary Artery Disease
Diabetes Mellitus
Eligibility:
All Genders
21-90 years
Phase:
NA
Brief Summary
This will be a prospective randomized clinical trial comprising of n=300 diabetic patients, randomized to either dynamic (n=150) or conventional MPI (n=150) strategy. Healthcare resources utilization ...
Detailed Description
Diabetes mellitus poses unique problems to detection and management of coronary atherosclerosis. Among the diabetics, certain spectrums of coronary atherosclerosis may be missed on conventional myocar...
Eligibility Criteria
Inclusion
- Diabetic patients without known coronary artery disease referred for MPI
Exclusion
- History of percutaneous coronary intervention, coronary artery bypass graft surgery
- Asthma
- Chronic obstructive pulmonary disease (COPD)
- Presence of cardiac devices such as pacemakers and implantable cardiac defibrillators
Key Trial Info
Start Date :
March 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05343884
Start Date
March 15 2022
End Date
March 1 2026
Last Update
April 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Heart Centre Singapore
Singapore, Singapore, 169609